Although this
preclearance request is approved, there are several policy
questions which hcfa should address prior to initiating this study.
OMB will be transmitting a list of these questions separately.
Inventory as of this Action
Requested
Previously Approved
04/30/1986
04/30/1986
0
0
0
0
0
0
0
0
0
THE CLINICAL LAB DEMONSTRATION WILL
TEST WHETHER AN ALTERNATE REIMBURSEMENT SYSTEM CAN REDUCE THE COST
OF LAB SERVICES WITHOUT AFFECTING THE QUALITY OR TIMELINESS OF LAB
SERVICES. THE LAB COST INFORMATION IS REQUIRED TO DETERMINE IF
PRICE REDUCTION REPRESENTS COST SAVINGS AS OPPOSED TO COST
SHIFTING. THE PROVIDER SURVEY IS REQUIRED TO ASSESS THE QUALITY AND
TIMELINESS OF SERVICES.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.